(Date:11/5/2009)...ur H. Rubenstein, MBBCh, Executive Vice President...System, and Dean, School of Medicine, will receive...ce to Medical Education from the Association of Am...presented on Saturday, Nov. 7, during the associat...Award was established by the AAMC in 1958 to recog...
(Date:11/5/2009)... The goal of the “Hopes and Dreams Quil...awareness about the disease, raise funds for The A... an online raffle and auction of the quilts, and &...quo; , Calabasas Hills, C...er who helps take care of someone living with ALS ...
(Date:11/5/2009).... 5 Cadence Pharmaceutic...mpany focused on in-licensing, developing and comm...ally for use in the hospital setting, today report... ended September 30, 2009. ,, Based upon the Pr...adence,s New Drug Application (NDA) for Acetavance...
(Date:11/5/2009)...5 STINSON Brand Innovation is offe...ce Nightingale in recognition of National Nurse Pr...s one in a series of e-books titled I nn ov a ... downloaded for no charge at http://www.stinsonbr..., "This is a way we celebrate the vital role of...
(Date:11/5/2009)...o finds unique mix of bacteria for each person ,... new "atlas" of bacterial life on and within the h...feet and forearms are a veritable United Nations o...gene-sequencing technologies, pinpointed specific ...nd within the body. They found a wide variability ...
Breaking Medicine News(10 mins):Health News:Penn's Arthur H. Rubenstein receives Distinguished Service award from AAMC 2Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 2Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 3Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 4Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 5Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 2Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 3Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 4Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 5Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 6Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 7Health News:National Nurse Practitioner Week Recognized by STINSON Brand Innovation With Offer of 'Notes on Nursing' e-book 2Health News:Germs Mingle Most on Palms, Feet, Forearms 2Health News:Germs Mingle Most on Palms, Feet, Forearms 3...n who diet during pregnancy are putting their chil...Researchers at the University of Southampton used ...ess of more than 200 nine-year-old children whose ...wer the mother's intake during pregnancy, the thic...
...ndian student who completed a management course he...struggling to cope with the effects of the trial a...
Navneet Modi, the student, agreed to a drug tri...and medication to stop his skin itching.
Lon...
...eased obesity in the United States has almost doub...exams during over a 15-year period, according to a....
Researchers assessed all radiology exams p...an effort to quantify how obesity affects diagnost...
...process by which a specific cell protein trigger t...gh scientists.//
The study by researchers in t...ancer Research Centre could pave the way for new d...cer preventing protein called p53. In some of the ...
...vernment body issued a warning today that thousand...ially lethal doses of radiation.//
The warn...e of Ireland (RPII) came after a house in Kerry wa...carcinogen and has been linked to 200 lung cancer...
...rong warning was issued by Britain's prime ministe...of the products that were not-so- healthy to child...motional ads that target minors.
In a broad ...e unhealthy food advertising to children in 2007. ...
Other Medicine News:Health News:Obesity Hinders Medical Diagnostic Tests 2Health News:Irish Households Exposed To Lethal Radiation 2(Date:11/5/2009)...ov. 5 A new laser therap...e,s eyes more efficiently and with greater precisi...an Academy of Ophthalmology (AAO) annual meeting. ...ls outside the USA, was developed by LenSar, a sta...on with two other players to be the first to comme...
(Date:11/4/2009)...ss., Nov. 4 GSI Group In... precision technology and semiconductor systems, t...the Nasdaq Hearings Panel that the Panel has deter...aq Stock Market and will suspend trading in the Co...n November 5, 2009. The Panel,s determination was ...
(Date:11/4/2009)...if., Nov. 4 Raptor Pharm...that data from a clinical trial of NGX426, the Com...e antagonist, will be presented at the 12th Intern... of Neuropathic Pain, to be held November 20-21, 2...wscom.com/cgi-bin/prnh/20071022/NYM074LOGO ) ,...
Breaking Medicine Technology:LenSar: New Laser Cure for Cataracts 2GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance 2GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance 3GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance 4GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance 5GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance 6Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference 2Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference 3Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference 4Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference 5Research institutes from Bremen install new Arctic deep sea observatory 9558 1Research institutes from Bremen install new Arctic deep sea observatory 9558 2Research institutes from Bremen install new Arctic deep sea observatory 9558 3Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study 13550 1Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study 13550 2Angiotech receives approval for Quill 28TM 29 SRS PDO MONODERM 28TM 29 Polypropylene and Nylon product lines for sale in Brazil 13547 1Angiotech receives approval for Quill 28TM 29 SRS PDO MONODERM 28TM 29 Polypropylene and Nylon product lines for sale in Brazil 13547 2Angiotech receives approval for Quill 28TM 29 SRS PDO MONODERM 28TM 29 Polypropylene and Nylon product lines for sale in Brazil 13547 3Angiotech receives approval for Quill 28TM 29 SRS PDO MONODERM 28TM 29 Polypropylene and Nylon product lines for sale in Brazil 13547 4...ity with No Clinically Significant ...Call Scheduled for 8:30AM (ET) Today-, PRINCETON,... is presenting safety, tolerability, pharmacokinet... doses of R7128 at the 14th,International Symposiu...eld,from September 9-13, 2007 in Glasgow, Scotland...
...d Symptoms Compared to Placebo, SEATTLE, Sept. 10...day announced preliminary analysis of results from...trolled, multicenter,clinical trial of its TRU-015...The results indicated that Trubion,s TRU-015 produ...statistically significant improvements in,RA signs...
Other Medicine Technology:Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 2Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 3Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 4Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 5Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 2Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 3Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 4Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 5Lo-Pro®/Lo-Contour® Tracheal Tube
Oral RAE® Tracheal Tube
Cuffed EndoFlex Endotracheal Tube
...ew Level 1 H-1200 Fast Flow Fluid Warmer, a new ge...efits of the existing Level 1 Fast Flow Fluid Warm...Warmer incorporates the features of integrated air...e continuing to deliver warm fluids as fast as 1,0...
Medicine Products: